Arbeitsgruppe CUP-Syndrom - Studien
CUP – palliative Therapie, 1st-line

AIO-assoziierte Studie   ClinicalTrials.gov zur Studie

Open labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated CUP (PACET-CUP)
  ---in Rekrutierung---